Plerixafor Injection
Product Images NDC 70771-1776

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 70771-1776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 01)

Label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) subcutaneous injection by Zydus Lifesciences Limited. The label includes the NDC number 70771-1776-1, specifies a single-dose vial with instructions to discard unused portion, indicates the container closure is latex-free, and states the product is made in India.*

FDA Label Image

Carton Label (41b76e97 B780 4fc8 B073 13bf155ad8a5 02)

Packaging label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) by Zydus Lifesciences Limited. The label indicates the product is for subcutaneous injection only, supplied in a single-dose vial, and includes storage and usage instructions. The label features the NDC 70771-1776-1 and specifies it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.